Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease

Publisher： Karger

E-ISSN： 2235-3186|129|1|29-33

ISSN： 1660-8151

Source： Nephron, Vol.129, Iss.1, 2014-12, pp. : 29-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial

By  

American Journal of Nephrology, Vol. 44, Iss. 1, 2016-07 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-02 ,pp. : 257-266

Karger

Access to resources Recommend Favorite

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 5, 2017-03 ,pp. : 380-388

Karger

Access to resources Recommend Favorite

The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease

By  

Nephron Extra, Vol. 3, Iss. 1, 2013-07 ,pp. : 66-72

Karger

Access to resources Recommend Favorite

Coronary Artery Calcification and Outcomes in Diabetic Patients with and without Chronic Kidney Disease

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 17-20

Karger

Access to resources Recommend Favorite